Publications by authors named "Michael D Rawlins"

Claim this Profile
T
The UK's Life Sciences Strategy: opportunities for clinical pharmacology.
Michael D Rawlins

Br J Clin Pharmacol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prevalence of Huntington's Disease.
Michael D Rawlins, Nancy S Wexler, Alice R Wexler, Sarah J Tabrizi, Ian Douglas

Neuroepidemiology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost, Effectiveness, and Value: How to Judge?
Michael D Rawlins

JAMA· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.
Nancy S Wexler, Laura Collett, Alice R Wexler, Michael D Rawlins, Sarah J Tabrizi

BMJ Open· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Institute for Clinical Excellence: NICE works.
Michael D Rawlins

J R Soc Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author's reply to Poole, Conway, Bewley, Sundar, and Chalmers and Firkins.
Michael D Rawlins

BMJ· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Saatchi bill" will allow responsible innovation in treatment.
Michael D Rawlins

BMJ· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence, values, and decision making.
Michael D Rawlins

Int J Technol Assess Health Care· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacologists in pharmacoeconomics: what is their role?
Michael D Rawlins

Expert Rev Clin Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engaging with health-care policy.
Michael D Rawlins

Lancet· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.
Stephen J W Evans, Ian Douglas, Michael D Rawlins, Nancy S Wexler, Sarah J Tabrizi

J Neurol Neurosurg Psychiatry· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population approach to the rational use of therapeutic interventions.
Michael D Rawlins

Clin Ther· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HTA and value--a commentary.
Michael D Rawlins

Int J Technol Assess Health Care· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE: moving onward.
Michael D Rawlins

N Engl J Med· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology in health care, teaching and research.
Michael D Rawlins

Br J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?
Michael D Rawlins

Eur J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Juvenile Huntington's disease: a population-based study using the General Practice Research Database.
Ian Douglas, Stephen Evans, Michael D Rawlins, Liam Smeeth, Sarah J Tabrizi

BMJ Open· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's happening at NICE?
Michael D Rawlins, Andrew Dillon, Gillian Leng

Clin Med (Lond)· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Of snarks, boojums and national drug charts.
Michael D Rawlins

J R Soc Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crossing the fourth hurdle.
Michael D Rawlins

Br J Clin Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness research: a view from the other side of the pond.
Michael D Rawlins

J Comp Eff Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The opportunity cost of cancer care: a statement from NICE.
Michael D Rawlins, Kalipso Chalkidou

Lancet Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: the death of clinical freedom.
Michael D Rawlins

Int J Epidemiol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The decade of NICE.
Michael D Rawlins

Lancet· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UK's NHS and pharma: need for more clinical pharmacologists.
Jeffrey K Aronson, David B Barnett, Alasdair M Breckenridge, Robin E Ferner, Peter Jackson, Michael D Rawlins

Lancet· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis